Clinical trial
Improving Outcomes in Patients With Comorbid T2DM and ASCVD: Population Health Management Interventions Supporting Guideline-recommended SGLT2i and GLP-1 RA Medications
NCT04862858 is registered in ClinicalTrials.gov with Humana Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Improving Outcomes in Patients With Comorbid T2DM and ASCVD: Population Health Management Interventions Supporting Guideline-recommended SGLT2i and GLP-1 RA Medications
- Lead sponsor
- Humana Inc.
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- August 18, 2021
- Completion date
- August 16, 2022
- Enrollment
- 4,197 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.